<h2>Publications</h2>

<ol>
  <li>
    Alam, S. S. M., Mir, S. A., Samanta, A., Ali, S., & Hoque, M. (2025).
    <strong>Structure-guided identification of phytochemical inhibitors targeting Programmed Death Ligand-1 protein for cancer immunotherapy.</strong>
    <em>ChemistrySelect</em> (Accepted).
  </li>

  <li>
    Alam, S. S. M., Mir, S. A., Samanta, A., Nayak, B., Ali, S., & Hoque, M. (2025).
    <strong>Immunoinformatics based designing of a multi-epitope cancer vaccine targeting programmed cell death ligand 1.</strong>
    <em>Scientific Reports</em>, 15(1).
    <br>
    DOI: <a href="https://doi.org/10.1038/s41598-025-87063-y" target="_blank">
    https://doi.org/10.1038/s41598-025-87063-y</a>
  </li>

  <li>
    Alam, S. S. M., Samanta, A., Ali, S., & Hoque, M. (2025).
    <strong>Structural insights into the impacts of non-synonymous single nucleotide polymorphisms in CD274 gene on the PD-1/PD-L1 interaction: An in silico approach.</strong>
    <em>Biochemical and Biophysical Research Communications</em>, 152679.
    <br>
    DOI: <a href="https://doi.org/10.1016/j.bbrc.2025.152679" target="_blank">
    https://doi.org/10.1016/j.bbrc.2025.152679</a>
  </li>

  <li>
    Alam, S. S. M., Mondal, R. H., Samanta, A., Mir, S. A., Nayak, B., Ali, S., & Hoque, M. (2025).
    <strong>Mapping pharmacological network to identify common molecular targets of epigallocatechin-3-gallate (EGCG) in inflammation and cancer.</strong>
    <em>Journal of Computational Biophysics and Chemistry</em>, 1–16.
    <br>
    DOI: <a href="https://doi.org/10.1142/s2737416526500304" target="_blank">
    https://doi.org/10.1142/s2737416526500304</a>
  </li>

  <li>
    Samanta, A., Karim, A., Ahamed, A., Hassan, M. K., Alam, S. S. M., Ali, S., & Hoque, M. (2025).
    <strong>Damaging non-synonymous mutations in the extracellular domain of HER2 potentially alter the efficacy of Herceptin-mediated breast cancer therapy.</strong>
    <em>Egyptian Journal of Medical Human Genetics</em>, 26(1).
    <br>
    DOI: <a href="https://doi.org/10.1186/s43042-025-00775-8" target="_blank">
    https://doi.org/10.1186/s43042-025-00775-8</a>
  </li>

  <li>
    Gorain, C., Gupta, S., Alam, S. S. M., Hoque, M., Karlyshev, A. V., & Mallick, A. I. (2024).
    <strong>Identification and functional characterization of putative ligand binding domain(s) of JlpA protein of Campylobacter jejuni.</strong>
    <em>International Journal of Biological Macromolecules</em>, 264, 130388.
    <br>
    DOI: <a href="https://doi.org/10.1016/j.ijbiomac.2024.130388" target="_blank">
    https://doi.org/10.1016/j.ijbiomac.2024.130388</a>
  </li>

  <li>
    Ahamed, A., Samanta, A., Alam, S. S. M., Mir, S. A., Jamil, Z., Ali, S., & Hoque, M. (2024).
    <strong>Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment.</strong>
    <em>Journal of Cellular Biochemistry</em>, 125(2).
    <br>
    DOI: <a href="https://doi.org/10.1002/jcb.30515" target="_blank">
    https://doi.org/10.1002/jcb.30515</a>
  </li>

  <li>
    Samanta, A., Ahamed, A., Alam, S. S. M., Ali, S., Khan, M. S., Al-Amri, A. M., Tabrez, S., & Hoque, M. (2023).
    <strong>Non-synonymous single nucleotide polymorphisms in human ACE2 gene may affect the infectivity of SARS-CoV-2 Omicron subvariants.</strong>
    <em>Current Pharmaceutical Design</em>, 29(36), 2891–2901.
    <br>
    DOI: <a href="https://doi.org/10.2174/0113816128275739231106055502" target="_blank">
    https://doi.org/10.2174/0113816128275739231106055502</a>
  </li>

  <li>
    Hassan, M. S., Alam, S. S. M., Samanta, A., Hoque, M., & Ali, S. (2023).
    <strong>Codon usage patterns of the eleven SARS-CoV-2 variants with reference to the Wuhan sequence.</strong>
    <em>Gene Reports</em>, 34, 101861.
    <br>
    DOI: <a href="https://doi.org/10.1016/j.genrep.2023.101861" target="_blank">
    https://doi.org/10.1016/j.genrep.2023.101861</a>
  </li>

  <li>
    Ahamed, A., Hasan, M., Samanta, A., Alam, S. S. M., Jamil, Z., Ali, S., & Hoque, M. (2023).
    <strong>Prospective pharmacological potential of cryptotanshinone in cancer therapy.</strong>
    <em>Pharmacological Research – Modern Chinese Medicine</em>, 9, 100308.
    <br>
    DOI: <a href="https://doi.org/10.1016/j.prmcm.2023.100308" target="_blank">
    https://doi.org/10.1016/j.prmcm.2023.100308</a>
  </li>

  <li>
    Alam, S. S. M., Samanta, A., Uddin, F., Ali, S., & Hoque, M. (2023).
    <strong>Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy.</strong>
    <em>Pharmacological Reports</em>, 75(4), 907–922.
    <br>
    DOI: <a href="https://doi.org/10.1007/s43440-023-00507-y" target="_blank">
    https://doi.org/10.1007/s43440-023-00507-y</a>
  </li>

  <li>
    Samanta, A., Alam, S. S. M., Ali, S., & Hoque, M. (2022).
    <strong>Evaluating the transmission feasibility of SARS-CoV-2 Omicron variant to 143 mammalian hosts.</strong>
    <em>Functional & Integrative Genomics</em>, 23(1).
    <br>
    DOI: <a href="https://doi.org/10.1007/s10142-023-00962-z" target="_blank">
    https://doi.org/10.1007/s10142-023-00962-z</a>
  </li>

  <li>
    Jamil, Z., Uddin, A., Alam, S. S. M., Samanta, A., Altwaijry, N., Rauf, M. A., Ali, S., Khan, M. S., Asghar, M. N., & Hoque, M. (2022).
    <strong>Analysis of the compositional features and codon usage pattern of genes involved in human autophagy.</strong>
    <em>Cells</em>, 11(20), 3203.
    <br>
    DOI: <a href="https://doi.org/10.3390/cells11203203" target="_blank">
    https://doi.org/10.3390/cells11203203</a>
  </li>

  <li>
    Alam, S. S. M., Uddin, F., Khan, F. B., Kamal, M. A., & Hoque, M. (2021).
    <strong>Therapeutic and pharmacological potential of Tanshinones against lung cancer: A systematic review.</strong>
    <em>Phytomedicine Plus</em>, 2(1), 100202.
    <br>
    DOI: <a href="https://doi.org/10.1016/j.phyplu.2021.100202" target="_blank">
    https://doi.org/10.1016/j.phyplu.2021.100202</a>
  </li>
</ol>

<h2>Book Chapters</h2>

<ol>
  <li>
    Alam, S. S. M., Jamil, Z., Samanta, A., Ali, S., & Hoque, M. (2025).
    <strong>Recent advances and future prospects of adoptive cell-based cancer immunotherapy.</strong>
    Elsevier eBooks.
    <br>
    DOI: <a href="https://doi.org/10.1016/b978-0-443-22300-6.00051-6" target="_blank">
    https://doi.org/10.1016/b978-0-443-22300-6.00051-6</a>
  </li>

  <li>
    Alam, S. S. M., Samanta, A., Jamil, Z., Ahamed, A., Ali, S., & Hoque, M. (2024).
    <strong>Systems vaccinology.</strong>
    Elsevier eBooks.
    <br>
    DOI: <a href="https://doi.org/10.1016/b978-0-443-22326-6.00018-3" target="_blank">
    https://doi.org/10.1016/b978-0-443-22326-6.00018-3</a>
  </li>

  <li>
    Jamil, Z., Ahamed, A., Samanta, A., Alam, S. S. M., Ali, S., & Hoque, M. (2024).
    <strong>Systems biology of cancer.</strong>
    Elsevier eBooks.
    <br>
    DOI: <a href="https://doi.org/10.1016/b978-0-443-22326-6.00023-7" target="_blank">
    https://doi.org/10.1016/b978-0-443-22326-6.00023-7</a>
  </li>

  <li>
    Ahamed, A., Samanta, A., Alam, S. S. M., Jamil, Z., Ali, S., & Hoque, M. (2024).
    <strong>High throughput data: Single-nucleotide polymorphisms in depth.</strong>
    Elsevier eBooks.
    <br>
    DOI: <a href="https://doi.org/10.1016/b978-0-443-22326-6.00009-2" target="_blank">
    https://doi.org/10.1016/b978-0-443-22326-6.00009-2</a>
  </li>

  <li>
    Alam, S. S. M., Samanta, A., Sultana, Z., Jamil, Z., Ali, S., & Hoque, M. (2024).
    <strong>Liposome-based nanomedicines for cancer immunotherapy.</strong>
    Elsevier eBooks.
    <br>
    DOI: <a href="https://doi.org/10.1016/b978-0-443-18770-4.00017-2" target="_blank">
    https://doi.org/10.1016/b978-0-443-18770-4.00017-2</a>
  </li>

  <li>
    Sultana, Z., Jamil, Z., Samanta, A., Alam, S. S. M., Ali, S., & Hoque, M. (2024).
    <strong>Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy.</strong>
    Elsevier eBooks.
    <br>
    DOI: <a href="https://doi.org/10.1016/b978-0-443-18770-4.00015-9" target="_blank">
    https://doi.org/10.1016/b978-0-443-18770-4.00015-9</a>
  </li>
</ol>
